Over the past 12 months, Achieve Life Sciences insiders sold $175,177 of stock on the open market (20.63K shares) and made no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Thomas Braxton King | Director | 315,142 | 0 | 315,142 | 32.2% | 08 Sep, 2025 |
| 2 | Richard Alistair Stewart | Chief Executive Officer | 208,249 | 0 | 208,249 | 21.3% | 21 Aug, 2026 |
| 3 | Mark K Oki | Chief Financial Officer | 127,940 | 0 | 127,940 | 13.1% | 22 Sep, 2025 |
| 4 | Cindy Jacobs | President Cmo | 115,585 | 0 | 115,585 | 11.8% | 08 Sep, 2025 |
| 5 | John Bencich | Ceo | 100,636 | 0 | 100,636 | 10.3% | 20 Aug, 2024 |
| 6 | Jaime Xinos | Chief Commercial Officer | 74,432 | 0 | 74,432 | 7.6% | 08 Sep, 2025 |
| 7 | Jerry Wan | Principal Accounting Officer | 32,694 | 0 | 32,694 | 3.3% | 08 Sep, 2025 |
| 8 | Anthony Clarke | Cso | 3,502 | 0 | 3,502 | 0.4% | 29 Apr, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 05 Oct, 2026 | Benjamin Halladay | Chief Financial Officer | Acquired A | 200,000 | $0.00 | $0 | 200,000 | Direct |
| 05 Oct, 2026 | Benjamin Halladay | Chief Financial Officer | Acquired A | 200,000 | $0.00 | $0 | 200,000 | Direct |
| 19 Aug, 2026 | Richard Alistair Stewart | Director | Disposed S | 20,626 | $8.49 | $175.18K | 208,249 | Direct |
| 27 Jul, 2026 | Reid Alexander Waldman | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 27 Jul, 2026 | Jeffrey S Farrow | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 27 Jul, 2026 | Richard Alistair Stewart | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 27 Jul, 2026 | Thomas Sellig | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 27 Jul, 2026 | Christopher Nathan Martin | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 27 Jul, 2026 | Nancy R. Phelan | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 27 Jul, 2026 | Aaron Royston | Director | Acquired A | 25,000 | $0.00 | $0 | 25,000 | Direct |
| 27 Jul, 2026 | Nancy R. Phelan | Director | Acquired A | 16,700 | $0.00 | $0 | 16,700 | Direct |
| 27 Jul, 2026 | Richard Alistair Stewart | Director | Acquired A | 16,700 | $0.00 | $0 | 16,700 | Direct |
| 27 Jul, 2026 | Aaron Royston | Director | Acquired A | 16,700 | $0.00 | $0 | 16,700 | Direct |
| 27 Jul, 2026 | Reid Alexander Waldman | Director | Acquired A | 16,700 | $0.00 | $0 | 16,700 | Direct |
| 27 Jul, 2026 | Thomas Sellig | Director | Acquired A | 16,700 | $0.00 | $0 | 16,700 | Direct |
| 27 Jul, 2026 | Christopher Nathan Martin | Director | Acquired A | 16,700 | $0.00 | $0 | 16,700 | Direct |
| 27 Jul, 2026 | Jeffrey S Farrow | Director | Acquired A | 16,700 | $0.00 | $0 | 16,700 | Direct |
| 29 May, 2026 | Reid Alexander Waldman | Director | Acquired A | 47,250 | $0.00 | $0 | 47,250 | Direct |
| 29 May, 2026 | Jeffrey S Farrow | Director | Acquired A | 47,250 | $0.00 | $0 | 47,250 | Direct |
| 11 May, 2026 | Christopher Nathan Martin | Director | Acquired A | 47,250 | $0.00 | $0 | 47,250 | Direct |